Erratum: The HIV fusion peptide adopts intermolecular parallel β-sheet structure in membranes when stabilized by the adjacent N-terminal heptad repeat: A 13C FTIR study (Journal of Molecular Biology (2005) 350 (790-805) PII: S0022-2836(05)00573-5 and DOI: 10.1016/j.jmb.2005.05.030);The HIV fusion peptide adopts intermolecular parallel β-sheet structure in membranes when stabilized by the adjacent N-terminal heptad repeat: A 13C FTIR study

Journal of Molecular Biology

Volumn 350, Issue 4, 2005, Pages 790-805

  Sackett, Kelly ^a   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Fusion peptide; Heptad repeat; HIV 1; Parallel sheet; Retrovirus

Indexed keywords

HIV FUSION PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; GENE CONSTRUCT; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MEMBRANE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 20544473941     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.06.058     Document Type: Erratum

References (85)

1. F.D. Veronese, A.L. DeVico, T.D. Copeland, S. Oroszlan, R.C. Gallo, and M.G. Sarngadharan Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene Science 229 1985 1402 1405
2. R.J. Center, R.D. Leapman, J. Lebowitz, L.O. Arthur, P.L. Earl, and B. Moss Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface J. Virol. 76 2002 7863 7867
3. P.L. Jones, T. Korte, and R. Blumenthal Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors J. Biol. Chem. 273 1998 404 409
4. D.C. Chan, and P.S. Kim HIV entry and its inhibition Cell 93 1998 681 684
5. R.A. Furuta, C.T. Wild, Y. Weng, and C.D. Weiss Capture of an early fusion-active conformation of HIV-1 gp41 Nature Struct. Biol. 5 1998 276 279
6. I. Munoz-Barroso, S. Durell, K. Sakaguchi, E. Appella, and R. Blumenthal Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41 J. Cell Biol. 140 1998 315 323
7. D.C. Chan, D. Fass, J.M. Berger, and P.S. Kim Core structure of gp41 from the HIV envelope glycoprotein Cell 89 1997 263 273
8. W. Weissenhorn, A. Dessen, S.C. Harrison, J.J. Skehel, and D.C. Wiley Atomic structure of the ectodomain from HIV-1 gp41 Nature 387 1997 426 430
9. T. Koshiba, and D.C. Chan The prefusogenic intermediate of HIV-1 gp41 contains exposed C-peptide regions J. Biol. Chem. 278 2003 7573 7579
10. C.A. Bewley, J.M. Louis, R. Ghirlando, and G.M. Clore Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41 J. Biol. Chem. 277 2002 14238 14245
11. F.M. Hughson Enveloped viruses: a common mode of membrane fusion? Curr. Biol. 7 1997 R565 R569
12. R.M. Markosyan, F.S. Cohen, and G.B. Melikyan HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation Mol. Biol. Cell 14 2003 926 938
13. K. Sackett, and Y. Shai How structure correlates to function for membrane associated HIV-1 gp41 constructs corresponding to the N-terminal half of the ectodomain J. Mol. Biol. 333 2003 47 58
14. C. Wild, J.W. Dubay, T. Greenwell, T. Baird Jr, T.G. Oas, C. McDanal, E. Hunter, and T. Matthews Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex Proc. Natl Acad. Sci. USA 91 1994 12676 12680
15. C. Wild, T. Oas, C. McDanal, D. Bolognesi, and T. Matthews A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition Proc. Natl Acad. Sci. USA 89 1992 10537 10541
16. S. Jiang, K. Lin, N. Strick, and A.R. Neurath HIV-1 inhibition by a peptide Nature 365 1993 113
17. C.H. Chen, T.J. Matthews, C.B. McDanal, D.P. Bolognesi, and M.L. Greenberg A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion J. Virol. 69 1995 3771 3777
18. H. Schaal, M. Klein, P. Gehrmann, O. Adams, and A. Scheid Requirement of N-terminal amino-acid-residues of Gp41 for human-immunodeficiency-virus type 1-mediated cell-fusion J. Virol. 69 1995 3308 3314
19. E.O. Freed, E.L. Delwart, G.L. Buchschacher Jr, and A.T. Panganiban A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity Proc. Natl Acad. Sci. USA 89 1992 70 74
20. E.O. Freed, D.J. Myers, and R. Risser Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41 Proc. Natl Acad. Sci. USA 87 1990 4650 4654
21. M.D. Delahunty, I. Rhee, E.O. Freed, and J.S. Bonifacino Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues Virology 218 1996 94 102
22. D. Gerber, M. Pritsker, S. Gunther-Ausborn, B. Johnson, R. Blumenthal, and Y. Shai Inhibition of HIV-1 envelope glycoprotein-mediated cell fusion by a DL-amino acid-containing fusion peptide: possible recognition of the fusion complex J. Biol. Chem. 279 2004 48224 48230
23. Y. Kliger, A. Aharoni, D. Rapaport, P. Jones, R. Blumenthal, and Y. Shai Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion. Structure-function study J. Biol. Chem. 272 1997 13496 13505
24. P. Durrer, Y. Gaudin, R.W. Ruigrok, R. Graf, and J. Brunner Photolabeling identifies a putative fusion domain in the envelope glycoprotein of rabies and vesicular stomatitis viruses J. Biol. Chem. 270 1995 17575 17581
25. S.R. Durell, I. Martin, J.M. Ruysschaert, Y. Shai, and R. Blumenthal What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review) Mol. Membr. Biol. 14 1997 97 112
26. J.M. White Membrane fusion Science 258 1992 917 924
27. J. Yang, C.M. Gabrys, and D.P. Weliky Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide Biochemistry 40 2001 8126 8137
28. V.A. Slepushkin, S.M. Andreev, M.V. Sidorova, G.B. Melikyan, V.B. Grigoriev, and V.M. Chumakov Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function AIDS Res. Hum. Retroviruses 8 1992 9 18
29. F.B. Pereira, F.M. Goni, A. Muga, and J.L. Nieva Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects Biophys. J. 73 1997 1977 1986
30. S.G. Peisajovich, R.F. Epand, M. Pritsker, Y. Shai, and R.M. Epand The polar region consecutive to HIV-1 fusion peptide participates in membrane fusion Biochemistry 39 2000 1826 1833
31. M. Rafalski, J.D. Lear, and W.F. DeGrado Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41 Biochemistry 29 1990 7917 7922
32. I. Martin, F. Defrise-Quertain, E. Decroly, M. Vandenbranden, R. Brasseur, and J.M. Ruysschaert Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes Biochim. Biophys. Acta 1145 1993 124 133
33. L.M. Gordon, C.C. Curtain, Y.C. Zhong, A. Kirkpatrick, P.W. Mobley, and A.J. Waring The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation Biochim. Biophys. Acta 1139 1992 257 274
34. C. Curtain, F. Separovic, K. Nielsen, D. Craik, Y. Zhong, and A. Kirkpatrick The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids Eur. Biophys. J. 28 1999 427 436
35. J. Yang, M. Prorok, F.J. Castellino, and D.P. Weliky Oligomeric beta-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers Biophys. J. 87 2004 1951 1963
36. K. Sackett, and Y. Shai The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion Biochemistry 41 2002 4678 4685
37. J.L. Nieva, S. Nir, A. Muga, F.M. Goni, and J. Wilschut Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage Biochemistry 33 1994 3201 3209
38. J. Yang, and D.P. Weliky Solid-state nuclear magnetic resonance evidence for parallel and antiparallel strand arrangements in the membrane-associated HIV-1 fusion peptide Biochemistry 42 2003 11879 11890
39. R. Yang, J. Yang, and D.P. Weliky Synthesis, enhanced fusogenicity, and solid state NMR measurements of cross-linked HIV-1 fusion peptides Biochemistry 42 2003 3527 3535
40. 11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes Biochemistry 38 1999 11359 11371
41. P.W. Mobley, A.J. Waring, M.A. Sherman, and L.M. Gordon Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs Biochim. Biophys. Acta 1418 1999 1 18
42. I. Martin, H. Schaal, A. Scheid, and J.M. Ruysschaert Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer J. Virol. 70 1996 298 304
43. 13C-enhanced Fourier transform infrared spectroscopy J. Pept. Res. 55 2000 330 347
44. L.M. Gordon, P.W. Mobley, R. Pilpa, M.A. Sherman, and A.J. Waring Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using (13)C-enhanced Fourier transform infrared spectroscopy Biochim. Biophys. Acta 1559 2002 96 120
45. L.M. Gordon, P.W. Mobley, W. Lee, S. Eskandari, Y.N. Kaznessis, M.A. Sherman, and A.J. Waring Conformational mapping of the N-terminal peptide of HIV-1 gp41 in lipid detergent and aqueous environments using 13C-enhanced Fourier transform infrared spectroscopy Protein Sci. 13 2004 1012 1030
46. P. Poumbourios, K.A. Wilson, R.J. Center, W. El Ahmar, and B.E. Kemp Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence J. Virol. 71 1997 2041 2049
47. H.B. Bernstein, S.P. Tucker, S.R. Kar, S.A. McPherson, D.T. McPherson, and J.W. Dubay Oligomerization of the hydrophobic heptad repeat of gp41 J. Virol. 69 1995 2745 2750
48. R.A. Silva, W. Barber-Armstrong, and S.M. Decatur The organization and assembly of a beta-sheet formed by a prion peptide in solution: an isotope-edited FTIR study J. Am. Chem. Soc. 125 2003 13674 13675
49. L. Tadesse, R. Nazarbaghi, and L. Walters Isotopically enhanced infrared-spectroscopy - a novel method for examining secondary structure at specific sites in conformationally heterogeneous peptides J. Am. Chem. Soc. 113 1991 7036 7037
50. C. Paul, J.P. Wang, W.C. Wimley, R.M. Hochstrasser, and P.H. Axelsen Vibrational coupling, isotopic editing, and beta-sheet structure in a membrane-bound polypeptide J. Am. Chem. Soc. 126 2004 5843 5850
51. C.F. Ludlam, I.T. Arkin, X.M. Liu, M.S. Rothman, P. Rath, and S. Aimoto Fourier transform infrared spectroscopy and site-directed isotope labeling as a probe of local secondary structure in the transmembrane domain of phospholamban Biophys. J. 70 1996 1728 1736
52. K.J. Halverson, I. Sucholeiki, T.T. Ashburn, and P.T. Lansbury Location of beta-sheet-forming sequences in amyloid proteins by FTIR J. Am. Chem. Soc. 113 1991 6701 6703
53. J.W. Brauner, C. Dugan, and R. Mendelsohn C-13 isotope labeling of hydrophobic peptides. Origin of the anomalous intensity distribution in the infrared amide I spectral region of beta-sheet structures J. Am. Chem. Soc. 122 2000 677 683
54. M.A. Baldwin Stable isotope-labeled peptides in study of protein aggregation Methods Enzymol. 309 1999 576 591
55. T.T. Ashburn, M. Auger, and P.T. Lansbury The structural basis of pancreatic amyloid formation - isotope-edited spectroscopy in the solid-state J. Am. Chem. Soc. 114 1992 790 791
56. R. Moritz, H. Fabian, U. Hahn, M. Diem, and D. Naumann Impact of four (13)C-proline isotope labels on the infrared spectra of ribonuclease T1 J. Am. Chem. Soc. 124 2002 6259 6264
57. J. Kubelka, and T.A. Keiderling The anomalous infrared amide I intensity distribution in C-13 isotopically labeled peptide beta-sheets comes from extended, multiple-stranded structures. An ab initio study J. Am. Chem. Soc. 123 2001 6142 6150
58. J. Bandekar Amide modes and protein conformation Biochim. Biophys. Acta 8 1992 123 143
59. M. Jackson, and H.H. Mantsch The use and misuse of FTIR spectroscopy in the determination of protein structure Crit. Rev. Biochem. Mol. Biol. 30 1995 95 120
60. S.A. Gallo, K. Sackett, S.S. Rawat, Y. Shai, and R. Blumenthal The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors J. Mol. Biol. 340 2004 9 14
61. A.M. Dwivedi, and S. Krimm Vibrational analysis of peptides, polypeptides, and proteins. XVIII. Conformational sensitivity of the alpha-helix spectrum: alpha I- and alpha II-poly(l-alanine) Biopolymers 23 1984 923 943
62. J. Nguyen, M.A. Baldwin, F.E. Cohen, and S.B. Prusiner Prion protein peptides induce alpha-helix to beta-sheet conformational transitions Biochemistry 34 1995 4186 4192
63. C. Hilbich, B. Kisters-Woike, J. Reed, C.L. Masters, and K. Beyreuther Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease J. Mol. Biol. 218 1991 149 163
64. P.T. Lansbury Jr, P.R. Costa, J.M. Griffiths, E.J. Simon, M. Auger, and K.J. Halverson Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide Nature Struct. Biol. 2 1995 990 998
65. O.N. Antzutkin, J.J. Balbach, R.D. Leapman, N.W. Rizzo, J. Reed, and R. Tycko Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils Proc. Natl Acad. Sci. USA 97 2000 13045 13050
66. T.L. Benzinger, D.M. Gregory, T.S. Burkoth, H. Miller-Auer, D.G. Lynn, R.E. Botto, and S.C. Meredith Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register Proc. Natl Acad. Sci. USA 95 1998 13407 13412
67. Y. Wexler-Cohen, K. Sackett, and Y. Shai The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils Biochemistry 44 2005 5853 5861
68. M. Lu, and P.S. Kim A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein J. Biomol. Struct. Dynam. 15 1997 465 471
69. Y. Kliger, S.G. Peisajovich, R. Blumenthal, and Y. Shai Membrane-induced conformational change during the activation of HIV-1 gp41 J. Mol. Biol. 301 2000 905 914
70. E. Gazit A possible role for pi-stacking in the self-assembly of amyloid fibrils FASEB J. 16 2002 77 83
71. R. Azriel, and E. Gazit Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation J. Biol. Chem. 276 2001 34156 34161
72. Y. Porat, Y. Mazor, S. Efrat, and E. Gazit Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions Biochemistry 43 2004 14454 14462
73. W.C. Wimley, K. Hristova, A.S. Ladokhin, L. Silvestro, P.H. Axelsen, and S.H. White Folding of beta-sheet membrane proteins: a hydrophobic hexapeptide model J. Mol. Biol. 277 1998 1091 1110
74. R. Ramachandran, R.K. Tweten, and A.E. Johnson Membrane-dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit beta-strand alignment Nature Struct. Mol. Biol. 11 2004 697 705
75. O. Shatursky, A.P. Heuck, L.A. Shepard, J. Rossjohn, M.W. Parker, A.E. Johnson, and R.K. Tweten The mechanism of membrane insertion for a cholesterol-dependent cytolysin: a novel paradigm for pore-forming toxins Cell 99 1999 293 299
76. L.V. Chernomordik, G.B. Melikyan, and Y.A. Chizmadzhev Biomembrane fusion: a new concept derived from model studies using two interacting planar lipid bilayers Biochim. Biophys. Acta 906 1987 309 352
77. L. Chernomordik, M.M. Kozlov, and J. Zimmerberg Lipids in biological membrane fusion J. Membr. Biol. 146 1995 1 14
78. C.M. Bishop, W.F. Walkenhorst, and W.C. Wimley Folding of beta-sheets in membranes: specificity and promiscuity in peptide model systems J. Mol. Biol. 309 2001 975 988
79. R.B. Harris, and I.B. Wilson tert-Butyl aminocarbonate (tert-butyloxycarbonyloxyamine) - a new acylating reagent for amines Int. J. Pept. Protein Res. 23 1984 55 60
80. R.B. Merrifield, L.D. Vizioli, and H.G. Boman Synthesis of the antibacterial peptide cecropin A (1-33) Biochemistry 21 1982 5020 5031
81. T.M. Hackeng, J.H. Griffin, and P.E. Dawson Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology Proc. Natl Acad. Sci. USA 96 1999 10068 10073
82. N. Boutonnet, W. Janssens, C. Boutton, J.L. Verschelde, L. Heyndrickx, and E. Beirnaert Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data J. Virol. 76 2002 7595 7606
83. T.C. Evans Jr, J. Benner, and M.Q. Xu Semisynthesis of cytotoxic proteins using a modified protein splicing element Protein Sci. 7 1998 2256 2264
84. W.K. Surewicz, H.H. Mantsch, and D. Chapman Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment Biochemistry 32 1993 389 394
85. C. Vigano, E. Goormaghtigh, and J.M. Ruysschaert Detection of structural and functional asymmetries in P-glycoprotein by combining mutagenesis and H/D exchange measurements Chem. Phys. Lipids 122 2003 121 135